Super-resolution microscopy for immune checkpoint inhibitors diagnostics
In the last decade, super-resolution microscopy techniques have emerged as powerful quantitative tools for biology. They have capabilities to visualize single molecules at the nanoscale opening the door to study biological process...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BioMarkerFlow
Fast and simple biomarker detection by computational microsc...
150K€
Cerrado
Cellularity
The critical shift to single-cell formats in functional anal...
5M€
Cerrado
EQC2021-007485-P
SISTEMA DE IMAGEN MOLECULAR POR CITOMETRIA DE MASAS
816K€
Cerrado
IOO - Improving IO
IOO: a novel assay to predict patient response to immune che...
4M€
Cerrado
FPSA13-1E-2048
Integrando la Medicina de Precisión a Nivel de la Célula Ind...
1K€
Cerrado
CTQ2017-85658-R
TG-DIAG: NUEVAS ESTRATEGIAS DE DIAGNOSTICO BASADAS EN FLUORE...
116K€
Cerrado
Información proyecto NANODIAGNOSTIC
Duración del proyecto: 18 meses
Fecha Inicio: 2022-11-10
Fecha Fin: 2024-05-31
Descripción del proyecto
In the last decade, super-resolution microscopy techniques have emerged as powerful quantitative tools for biology. They have capabilities to visualize single molecules at the nanoscale opening the door to study biological processes at a level not accessible before. In the ERC StG NANOSTORM we showed the potential of these techniques providing new fundamental knowledge on the mechanism and design of new targeted therapies. However, some of the methods we developed have the potential to be translated into applied clinical diagnostic tools. In NANODIAGNOSTIC, we would offer a proof-of-concept of the application of super resolution microscopy and single-molecule imaging for cancer diagnostic, with a focus on patients stratification for immunotherapy. Novel advances in immunotherapies have brought the development of immune checkpoint inhibitors (ICI) that re-activate the immune system against the tumor. Despite the high success of these therapies there is one main challenge: they are only effective on a limited portion of patients and current diagnostic approaches are not capable of stratifying patient successfully. NANODIAGNOSTIC will translate advance optical methods from an academic setting to the clinic and holds a great potential to provide new diagnostic methods to improve the outcome of immunotherapy.